Get Ready to Say Goodbye to Pain: Double Rainbow Unveils the World’s First Commercial-Scale Biosynthetic Gastrodin – A Natural Pain Reliever with Endless Possibilities!
The global Gastrodin market is expected to rise significantly over the next five years Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Marvel Lexington, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health, today announced the world’s first…